Category Annual Conference on Vaccine Research
Special thanks to Karie Youngdahl for this blog post from The History of Vaccines on vaccinology predictions presented at the 20th Annual Conference on Vaccine Research (ACVR) held in Bethesda, MD last month…
The Centers for Disease Control and Prevention (CDC) has designated April 22-29, 2017 as National Infant Immunization Week (NIIW), an annual observance highlighting the importance of protecting infants from vaccine-preventable diseases and celebrating the achievements of immunization programs and partners in promoting healthy communities. As NIIW coincides with the 2017 Annual Conference on Vaccine Research (April 24-26, 2017), […]
Special thanks to Kathryn M. Edwards, MD, Sarah H. Sell and Cornelius Vanderbilt Chair in Pediatrics and Director, Vanderbilt Vaccine Research Program at Vanderbilt University School of Medicine for sharing her acceptance speech for the 2016 Dr. Charles Mérieux Award for Achievement in Vaccinology and Immunology, delivered by William Schaffner, MD at the 2016 NFID Annual Conference on Vaccine Research.
Top news coverage from the NFID 19th Annual Conference on Vaccine Research on April 18-20, 2016 in Baltimore, MD…
The NFID 19th Annual Conference on Vaccine Research (April 18-20, 2016) organizers have developed a track of presentations and posters discussing maternal and infant immunization, in honor of National Infant Immunization Week.
With a focus on increasing awareness of patient safety among healthcare professionals and consumers, National Patient Safety Awareness Week provides an opportunity to highlight an issue that affects more than 700,000 patients each year—healthcare-associated infections.
A universal influenza vaccine would be an exciting new advancement and would revolutionize a vaccination strategy that has remained largely unchanged for over 50 years. An attractive future is on the rise in which an individual would need to receive only two vaccinations over his or her lifetime to protect against the many commonly circulating influenza virus strains, as well as possible emergent pandemic strains.